If you are wondering how Kearns-Sayre Syndrome (KSS) affects the production of energy inside the body, then this is the article for you. Here we will discuss KSS and break down the complex scientific terms related to mitochondrial dysfunction, which impacts energy production, daily life, and health.

KSS is a rare mitochondrial disorder that generally starts before the age of 20. It especially impacts tissues that require high energy levels to work, like the brain, your muscles, and heart. It impairs cells' capability to produce energy due to large-scale deletions in mitochondrial DNA (mtDNA).¹ 

Importance of mitochondria in energy production

Mitochondria are known as the "powerhouses of the cell” because they generate adenosine triphosphate (ATP), the primary energy currency of the cell. Mitochondria also support biogenesis (production of new mitochondria) and regulate cellular stress responses like autophagy (cellular recycling) and apoptosis (cellular death). They form a dynamic network closely linked to other parts of the cell and influence overall body function by mediating intercellular communication. Given their central role, mitochondrial dysfunction is a major contributor to many diseases, including neurodegenerative and metabolic disorders.²

Mitochondrial DNA and its role in KSS

Structure and function of mtDNA

Each mitochondria cell has its own set of DNA, known as mtDNA. This mtDNA is separate from the cell’s nuclear DNA and is much smaller in size, consisting of a circular molecule that carries just 37 genes. These genes play a major role in producing proteins essential for mitochondrial energy production, specifically proteins needed for a process called oxidative phosphorylation, which is how cells make most of their energy in the form of ATP.

Additionally, mtDNA has a role during fertilization, as specific genes located near the inner membrane of the mitochondria are passed down to children from their mothers. As mtDNA is in close proximity to reactive oxygen species (ROS), which are the byproducts of energy production and are known to cause oxidative stress and damage to DNA, mtDNA becomes more prone to mutations like deletions.³

How mtDNA deletions affect mitochondrial function

Large segments of mtDNA are missing in individuals with KSS due to the random deletion of some fragments. These deletions interfere with the mitochondria’s ability to produce the proteins required for the electron transport chain in mitochondria.

Because the electron transport chain is incomplete or dysfunctional, the mitochondria cannot effectively carry out oxidative phosphorylation. As a result, cells fail to produce adequate amounts of ATP, particularly in energy-hungry tissues such as the muscles, heart, and brain. 

In addition to poor energy output, damaged mitochondria may generate excess reactive oxygen species, which worsen the condition by causing further damage to both the mitochondria and surrounding cell structures.⁴

Oxidative phosphorylation and ATP production

Overview of oxidative phosphorylation

Oxidative phosphorylation is the most crucial step in the generation of ATP. This process takes place inside the inner membrane of mitochondria and involves a set of protein complexes known collectively as the electron transport chain. These complexes transfer electrons, which come from nutrients we consume, into each protein complex through a series of steps. The energy released during this process (ATP) is used to pump protons across the mitochondrial membrane, creating a gradient. This gradient helps an enzyme called ATP synthase, which uses the energy from the proton flow to convert ADP into ATP.⁵

Impact of mtDNA deletions on ATP synthesis

When mtDNA deletions occur, they often affect genes responsible for building essential parts of the electron transport chain, particularly Complexes I, III, and IV. If these complexes don’t work properly, oxidative phosphorylation cannot proceed. Thus, the flow of electrons slows, the proton gradient weakens, and ATP production drops.

In KSS, the resulting energy shortfall is most noticeable in tissues with high energy requirements. Muscle cells may weaken, heart tissue can develop conduction defects, and neurons may struggle to function, leading to a range of symptoms from fatigue and muscle weakness to vision and hearing problems. On top of that, impaired mitochondria tend to release more reactive oxygen species, fueling a cycle of ongoing mitochondrial damage and worsening symptoms.⁶

Clinical manifestations of KSS

Muscle-related symptoms

As we have discussed, the most common symptom is muscle weakness, particularly the muscles that control the eyes and eyelids. Many individuals experience progressive external ophthalmoplegia, a condition where eye movement becomes limited and eyelids begin to droop. This is caused due to the reduced generation of ATP by ocular muscles, causing them to weaken over time.

Beyond the eyes, broader muscular fatigue may occur, especially during physical activity. This fatigue reflects the inability of skeletal muscles to sustain contractions when mitochondria can’t produce enough energy.⁷

Cardiac involvement

The heart, which requires a continuous energy supply to maintain its rhythm and pumping action, is often affected in KSS. Cardiac conduction defects, such as atrioventricular block and arrhythmias, can develop due to energy failure in heart muscle cells. If left undiagnosed, these complications can lead to fainting, heart failure, or sudden cardiac death, making regular cardiac monitoring essential.⁸

In many cases, patients may need pacemakers or implantable defibrillators to manage these heart rhythm issues.

Neurological and sensory symptoms

The nervous system is the most important system that requires ATP for proper functioning. People with KSS may experience cerebellar ataxia, which affects balance and coordination, as well as hearing loss, which is typically progressive. Cognitive challenges, such as memory problems or learning difficulties, can also occur in some patients.

These symptoms reflect impaired mitochondrial energy production in neurons and glial cells. In more severe cases, seizures or stroke-like episodes may also be observed, particularly when KSS overlaps with other mitochondrial syndromes.⁶

Diagnosis and monitoring

Clinical and diagnostic criteria

Diagnosing KSS requires a combination of clinical features, laboratory findings, and genetic testing. The classic diagnostic triad includes:

• Onset before age 20
• Progressive external ophthalmoplegia (weakness or paralysis of the muscles that control eye movement)
• Pigmentary retinopathy (a characteristic degeneration of the retina)

Supporting tests often include:

• Muscle biopsy showing "ragged red fibers," which are clumps of abnormal mitochondria stained under the microscope
• mtDNA analysis to detect large-scale deletions
• Electrocardiograms (ECGs) to evaluate heart rhythm abnormalities
• Brain MRI or CT scans to detect atrophy or calcifications
• CSF (cerebrospinal fluid) analysis, which may show elevated protein levels

These tools help confirm the diagnosis and assess the extent of organ involvement.

Importance of early identification

Timely diagnosis of KSS is essential to prevent more serious health risks. Early detection allows physicians to anticipate complications, especially cardiac issues, and start preventive treatments that can significantly extend lifespan and improve quality of life. 

Regular follow-ups are key to monitoring disease progression and adjusting care accordingly.

Management strategies

Symptom-focused treatment

At present, there is no definitive cure for KSS. Management revolves around addressing individual symptoms and preventing further complications:

• Pacemaker implantation for cardiac conduction issues
• Hearing aids or cochlear implants for hearing loss
• Physical and occupational therapy to preserve mobility and muscle function
• Speech therapy is needed if the swallowing or speech muscles are affected
• Nutritional support, especially if gastrointestinal symptoms or swallowing difficulties are present

Patients benefit from multidisciplinary care involving cardiologists, neurologists, geneticists, audiologists, and physical therapists.

Investigational therapies and mitochondrial support

Some treatments aim to enhance mitochondrial function. Supplements such as coenzyme Q10, L-carnitine, and vitamin cocktails (e.g., B-complex, vitamin E, alpha-lipoic acid) are sometimes used to support energy metabolism. However, while some patients report modest improvement, robust clinical trials are still needed to confirm their effectiveness.⁹

Antioxidants may help reduce damage from reactive oxygen species, but again, evidence is mixed. These approaches are supportive rather than curative and should be considered part of a broader management plan.

Research and future directions

Current research efforts

A growing number of studies are focusing on mitochondrial diseases, including KSS. Research is exploring:

• Gene therapy approaches to correct mtDNA mutations or supplement mitochondrial function
• Mitochondrial replacement therapy (MRT), which may allow for healthier mitochondria to be passed on in families with inherited disorders
• Stem cell therapy to potentially regenerate damaged tissues or improve mitochondrial function
• Use of mitochondria-targeted compounds, such as MitoQ and elamipretide, in clinical trials

Many of these methods are still in early stages, but they represent hopeful prospects for altering the course of mitochondrial diseases like KSS.

Challenges in gene therapy

Unlike nuclear DNA, mitochondrial DNA is present in multiple copies per cell and exists outside the nucleus, which complicates traditional gene therapy. Researchers are working on delivery systems and molecular techniques capable of targeting mitochondria directly — a field that’s rapidly advancing but still years from routine clinical application.¹⁰

Conclusion

Kearns-Sayre Syndrome is a rare but serious mitochondrial disorder that affects multiple organ systems. It results from large deletions in mtDNA that disrupt oxidative phosphorylation, impairing the body’s ability to produce sufficient energy. This shortfall primarily impacts tissues that rely on constant ATP supply, including the muscles, heart, brain, and eyes.

While no cure exists yet, early diagnosis and a tailored, symptom-focused treatment approach can greatly enhance patient outcomes. Advances in mitochondrial biology and gene therapy may eventually lead to more definitive interventions.

Summary

• Cause: Large-scale deletions in mitochondrial DNA
• Main issue: Impaired oxidative phosphorylation → reduced ATP production
• Affected tissues: Muscles, heart, brain, eyes
• Symptoms: Muscle weakness, ptosis, heart block, hearing loss, coordination problems
• Diagnosis: Based on clinical signs, muscle biopsy, and mtDNA analysis
• Treatment: Symptom-focused; research is ongoing into targeted mitochondrial therapies
  

Frequently Asked Questions (FAQs)

Q: Is Kearns-Sayre Syndrome inherited?
A: Most cases are sporadic, meaning they arise from new mutations and are not passed from parents. However, in rare instances, maternal inheritance may occur due to the unique nature of mitochondrial DNA.

Q: Can lifestyle changes improve symptoms of KSS?
A: While lifestyle changes won't reverse the disease, maintaining a nutrient-rich diet, engaging in gentle physical activity, and getting regular check-ups can support overall health and symptom management.

Q: Are there preventive strategies for KSS?
A: Currently, there are no proven methods to prevent KSS. However, genetic counseling can help assess the risk of mitochondrial disorders in families with a history of related symptoms.